PTPRD and neoplasm: Additionally, we identified very frequent mutations (18 missense and 1 deleterious) in PTPRD (Figure 3C), a tumor suppressor frequently mutated in many cancers, including melanoma and cutaneous SCC (84–88), in 13 samples, but these have never been reported as frequently mutated in BCC.